IPS_001 - Development of a quantitative near-infrared spectroscopy method for Lisinopril analysis during the blending stage of tablet manufacturing

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: IPS_001
• By: GAMBOA, Alexander (Facultad de Química y Biología. Departamento Ciencias del ambiente. Universidad de Santiago, Chile)
• Co-author(s): Dr Alexander Gamboa (Facultad de Química y Biología. Departamento Ciencias del ambiente. Universidad de Santiago, Santiago, Chile)
  BSc Thamara Hidalgo (Facultad de Química y Biología. Departamento Ciencias del ambiente. Universidad de Santiago, Santiago, Chile)
  
• Abstract:

  Introduction: Lisinopril is a long-acting angiotensin-converting enzyme inhibitor used primarily for the treatment of hypertension. Its pharmaceutical form is available in oral tablet form in strengths ranging from 2.5 mg to 40 mg. Issues related to tablet strength arise primarily from inadequate blending uniformity, particularly in low-dose..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login